Infinity Pharmaceuticals Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 0/6

Infinity Pharmaceuticals has a total shareholder equity of $-37.4M and total debt of $47.8M, which brings its debt-to-equity ratio to -127.9%. Its total assets and total liabilities are $21.2M and $58.6M respectively.

Wichtige Informationen

-127.9%

Verhältnis von Schulden zu Eigenkapital

US$47.83m

Verschuldung

Zinsdeckungsgradn/a
BargeldUS$17.75m
Eigenkapital-US$37.41m
GesamtverbindlichkeitenUS$58.64m
GesamtvermögenUS$21.23m

Jüngste Berichte zur Finanzlage

Recent updates

Is Infinity Pharmaceuticals (NASDAQ:INFI) In A Good Position To Invest In Growth?

Nov 10
Is Infinity Pharmaceuticals (NASDAQ:INFI) In A Good Position To Invest In Growth?

Infinity Pharmaceuticals: Waiting For A Deal

Sep 08

Is Infinity Pharmaceuticals (NASDAQ:INFI) In A Good Position To Invest In Growth?

May 23
Is Infinity Pharmaceuticals (NASDAQ:INFI) In A Good Position To Invest In Growth?

We're Hopeful That Infinity Pharmaceuticals (NASDAQ:INFI) Will Use Its Cash Wisely

Dec 29
We're Hopeful That Infinity Pharmaceuticals (NASDAQ:INFI) Will Use Its Cash Wisely

Investigating Infinity Pharmaceuticals

Nov 25

Infinity Pharmaceuticals (NASDAQ:INFI) Is In A Good Position To Deliver On Growth Plans

Jul 18
Infinity Pharmaceuticals (NASDAQ:INFI) Is In A Good Position To Deliver On Growth Plans

Increases to Infinity Pharmaceuticals, Inc.'s (NASDAQ:INFI) CEO Compensation Might Cool off for now

Jun 03
Increases to Infinity Pharmaceuticals, Inc.'s (NASDAQ:INFI) CEO Compensation Might Cool off for now

Is Infinity Pharmaceuticals (NASDAQ:INFI) In A Good Position To Deliver On Growth Plans?

Apr 13
Is Infinity Pharmaceuticals (NASDAQ:INFI) In A Good Position To Deliver On Growth Plans?

Are Institutions Heavily Invested In Infinity Pharmaceuticals, Inc.'s (NASDAQ:INFI) Shares?

Feb 19
Are Institutions Heavily Invested In Infinity Pharmaceuticals, Inc.'s (NASDAQ:INFI) Shares?

Can You Imagine How Jubilant Infinity Pharmaceuticals' (NASDAQ:INFI) Shareholders Feel About Its 147% Share Price Gain?

Jan 15
Can You Imagine How Jubilant Infinity Pharmaceuticals' (NASDAQ:INFI) Shareholders Feel About Its 147% Share Price Gain?

Infinity Pharma to start new registration-enabling eganelisib study in urothelial cancer

Jan 06

Will Infinity Pharmaceuticals (NASDAQ:INFI) Spend Its Cash Wisely?

Dec 11
Will Infinity Pharmaceuticals (NASDAQ:INFI) Spend Its Cash Wisely?

Infinity Pharma slides after eganelisib data presentation at Breast Cancer Symposium

Dec 09

Infinity Pharmaceutical Reaching Vital New Staging Posts

Dec 01

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: INFI.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Langfristige Verbindlichkeiten: INFI.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: INFI.Q has negative shareholder equity, which is a more serious situation than a high debt level.

Schulden abbauen: INFI.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanz


Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: INFI.Q has less than a year of cash runway based on its current free cash flow.

Vorhersage Cash Runway: INFI.Q has less than a year of cash runway if free cash flow continues to reduce at historical rates of 2.2% each year


Entdecken Sie finanziell stabile Unternehmen